Aortic valve stenosis and cancer: a common and complex association

References

• Mortality by cause of death (29 December 2016). Statistics Bureau, Ministry of Internal Affairs and Communications. Accessed 2018 Feb 27. Available at: http://www.stat.go.jp/data/sekai/0116.htm#c14
   Google Scholar
• American Cancer Society. Cancer facts & figures. Atlanta: American Cancer Society; 2016; 2016.
   Google Scholar
• Carabello BA, Paulus WJ. Aortic stenosis. Lancet. 2009;373(9667):956‐966.
   PubMed Web of Science ®Google Scholar
• Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–1011.
   PubMed Web of Science ®Google Scholar
• Eveborn GW, Schirmer H, Heggelund G, et al. The evolving epidemiology of valvular aortic stenosis. Tromso Study Heart. 2013;99:396–400.
   PubMed Web of Science ®Google Scholar
• Danielsen R, Aspelund T, Harris TB, et al. The prevalence of aortic stenosis in the elderly in Iceland and predictions for the coming decades: the AGES-Reykjavik study. Int J Cardiol. 2014;176(3):916–922.
   PubMed Web of Science ®Google Scholar
• Bonow RO, Carabello B, De Leon AC Jr, Edmunds LH Jr, Fedderly BJ, Freed MD, Gaasch WH, McKay CR, Nishimura RA, O’Gara PT, O’Rourke RA, Rahimtoola SH. ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of patients with valvular heart disease). J Am Coll Cardiol. 1998; 32: 1486–1582.
   Google Scholar
• Bonow RO, Carabello B, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of valvular heart disease. J Am Coll Cardiol. 2006;48:e1–e148.
   PubMed Web of Science ®Google Scholar
• Giza DE, Iliescu G, Hassan S, et al. Cancer as a risk factor for cardiovascular disease. Curr Oncol Rep. 2017;19(39):1–8.
   PubMedGoogle Scholar
• Mangner N, Woitek FJ, Haussig S, et al. Impact of active cancer disease on the outcome of patients undergoing transcatheter aortic valve replacement. J Interven Cardiol. 2018;31(2):188–196.
   PubMed Web of Science ®Google Scholar
• Faggiano P, Frattini S, Zilioli V, et al., Prevalence of comorbidities and associated cardiac diseases in patients with valve aortic stenosis. Potential implications for the decision-making process. Int J Cardiol. 159(2): 94–99. 2012.
   PubMed Web of Science ®Google Scholar
• Guha A, Dey AK, Arora S, et al., Contemporary trends and outcomes of percutaneous and surgical aortic valve replacement in patients with cancer. J Am Heart Assoc. 2020; 9(2): e014248.
   PubMed Web of Science ®Google Scholar
• Okura Y, Ishigaki S, Sakakibara S, et al. Prognosis of cancer patients with aortic stenosis under optimal cancer therapies and conservative cardiac treatments. Int Heart J. 2018;6(4):750–758.
   Google Scholar
• Minamino-Muta E, Kato T, Morimoto T, et al. Malignant disease as a comorbidity in patients with severe aortic stenosis: clinical presentation, outcomes, and management. Eur Heart J Qual Care Clin Outcomes. 2018;4(3):180–188.
   PubMed Web of Science ®Google Scholar
• Mathieu P, Boulanger MC. Basic mechanisms of calcific aortic valve disease. Can J Cardiol. 2014;30(9):982–993.
   PubMed Web of Science ®Google Scholar
• Lindman BR, Clavel M-A, Mathieu P, et al. Calcific aortic stenosis. Nat Rev Dis Primers. 2016;2:16006.
   PubMed Web of Science ®Google Scholar
• Masoudkabir F, Sarrafzadegan N, Gotay N, et al. Cardiovascular disease and cancer: evidence for shared disease pathways and pharmacologic prevention. Atherosclerosis. 2017 August;263:343–351.
   PubMed Web of Science ®Google Scholar
• Katz R, Wong ND, Kronmal R, et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis. Circulation. 2006;113(17):2113–2119.
   PubMed Web of Science ®Google Scholar
• Mohler ER, Sheridan MJ, Nichols R, et al. Development and progression of aortic valve stenosis: atherosclerosis risk factors – a causal relationship? A clinical morphologic study. Clin Cardiol. 1991;14(12):995–999.
   PubMed Web of Science ®Google Scholar
• Paris S, Tarantini L, Navazio A, et al. Cardio-oncology: the new frontier of clinical and preventive cardiology. Monaldi Arch Chest Dis 2020; 90: 1348.
   Google Scholar
• Koene RJ, Prizment AE, Blaes A, et al. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;133(11):1104–1114.
   PubMed Web of Science ®Google Scholar
• Cancer. Geneva, Switzerland: World Health Organization. http://www.who.int/mediacentre/factsheets/fs297/en/). Accessed 2015 Dec 27
   Google Scholar
• Baumgartner H, Hung J, Bermejo J, et al., Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society Of Echocardiography. J Am Soc Echocardiogr. 2017; 30(4): 372–392.
   PubMed Web of Science ®Google Scholar
• Di Mario C, Eltchaninoff H, Moat N, et al. The 2011–12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients. EuroIntervention. 2013;8(12):1362–1371.
   PubMed Web of Science ®Google Scholar
• Hamm CW, Mollmann H, Holzhey D, et al. The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J. 2014;35:1588–1598.
   PubMed Web of Science ®Google Scholar
• Nashef SA, Roques F, Sharples LD, et al. II. Eur J Cardiothorac Surg. 2012;41(4):734–744.
   PubMed Web of Science ®Google Scholar
• STS National Database Risk Calculator. (December 2013). http://www.sts.org/sections/stsnationaldatabase/riskcalculator
   Google Scholar
• Hahn RT, Pibarot P, Stewart WJ, et al. Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves). J Am Coll Cardiol. 2013;61(25):2514–2521.
   PubMedGoogle Scholar
• Lauten A, Zahn R, Horack M, et al. Transcatheter aortic valve implantation in patients with low-flow, low-gradient aortic stenosis. JACC Cardiovasc Interv. 2012;5(5):552–559.
   PubMed Web of Science ®Google Scholar
• Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123(3):299–308.
   PubMed Web of Science ®Google Scholar
• Le Ven F, Freeman M, Webb J, et al. Impact of low flow on the outcome of high-risk patients undergoing transcatheter aortic valve replacement. J Am Coll Cardiol. 2013;62(9):782–788.
   PubMed Web of Science ®Google Scholar
• Zamorano JL, Lancellotti P, Dr M, et al. ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) European Heart Journal. 2016;37:2768–2801.
   Google Scholar
• Lenihan DJ, Oliva S, Chow EJ, et al. Cardiac toxicity in cancer survivors. Cancer. 2013;119(Suppl 11):2131–2142.
   PubMedGoogle Scholar
• Cardinale D, Colombo A, Lamantia G, et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol. 2010;55(3):213–220.
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–1607.
   PubMed Web of Science ®Google Scholar
• Mack MJ, Brennan JM, Brindis R, et al. Outcomes following transcatheter aortic valve replacement in the United States. JAMA. 2013;310(19):2069–2077.
   PubMed Web of Science ®Google Scholar
• Ruel M, Kapila V, Price J, et al. Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement. Circulation. 2006;114(1_suppl):I541–I546.
   PubMedGoogle Scholar
• Waisbren EC, Stevens LM, Avery EG, et al. Changes in mitral regurgitation after replacement of the stenotic aortic valve. Ann Thorac Surg. 2008;86(1):56–62.
   PubMed Web of Science ®Google Scholar
• Unger P, Dedobbeleer C, Van CG, et al. Mitral regurgitation in patients with aortic stenosis undergoing valve replacement. Heart. 2010;96(1):9–14.
   PubMed Web of Science ®Google Scholar
• Hekimian G, Detaint D, Messika-Zeitoun D, et al. Mitral regurgitation in patients referred for transcatheter aortic valve implantation using the Edwards Sapien prosthesis: mechanisms and early postprocedural changes. J Am Soc Echocardiogr. 2012;25(2):160–165.
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Eng J Med. 2010;363(17):1597–1607.
   PubMed Web of Science ®Google Scholar
• Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–2198.
   PubMed Web of Science ®Google Scholar
• Goel SS, Ige M, Tuzcu EM, et al. Severe aortic stenosis and coronary artery disease – implications for management in the transcatheter aortic valve replacement era: a comprehensive review. J Am Coll Cardiol. 2013;62(1):1–10.
   PubMed Web of Science ®Google Scholar
• Perez S, Thielhelm TP, Cohen MG. To revascularize or not before transcatheter aortic valve implantation? J Thorac Dis. 2018;10(Suppl 30):S3578–S3587.
   PubMedGoogle Scholar
• Ramee S, Anwaruddin S, Kumar G, et al. The rationale for performance of coronary angiography and stenting before transcatheter aortic valve replacement: from the interventional section leadership council of the American College Of Cardiology. JACC Cardiovasc Interv. 2016;9(23):2371–2375.
   PubMed Web of Science ®Google Scholar
• Nabialek-Trojanowska I, Lewicka E, Wrona A, et al. Cardiovascular complications after radiotherapy. Cardiol J. 2018;27(6):836–847.
   PubMed Web of Science ®Google Scholar
• Armanious MA, Mohammadi H, Khodor S, et al. Cardiovascular effects of radiation therapy. Curr Probl Cancer. 2018;42(4):433–442.
   PubMed Web of Science ®Google Scholar
• Copeland KA, Hosmane VR, Jurkovitz C, et al. Frequency of severe valvular disease caused by mediastinal radiation among patients undergoing valve surgery in a community-based, regional academic medical center. Clin Cardiol. 2013;36(4):217–221.
   PubMed Web of Science ®Google Scholar
• Mousavi N, Nohria A. Radiation-induced cardiovascular disease. Curr Treat Options Cardiovasc Med. 2013;15(5):507–517.
   PubMedGoogle Scholar
• Bouillon K, Haddy N, Delaloge S, et al. Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol. 2011;57(4):445–452.
   PubMed Web of Science ®Google Scholar
• Donnellan E, Masri A, Johnston DR, et al. Long-term outcomes of patients with mediastinal radiation-associated severe aortic stenosis and subsequent surgical aortic valve replacement: a matched cohort study. J Am Heart Assoc. 2017;6(5):5.
   Web of Science ®Google Scholar
• Carver JR, Shapiro CL, Ng A, et al. American society of clinical oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007;25(25):3991–4008.
   PubMed Web of Science ®Google Scholar
• Jaworski C, Mariani JA, Wheeler G, et al. Cardiac complications of thoracic irradiation. J Am Coll Cardiol. 2013;61(23):2319–2328.
   PubMed Web of Science ®Google Scholar
• Nadlonek NA, Weyant MJ, Yu JA, et al. Radiation induces osteogenesis in human aortic valve interstitial cells. J Thorac Cardiovasc Surg. 2012;144(6):1466–1470.
   PubMed Web of Science ®Google Scholar
• Gujral DM, Lloyd G, Bhattacharyya S. Radiation-induced valvular heart disease. Heart. 2016;102(4):269–276.
   PubMed Web of Science ®Google Scholar
• Boekel NB, Jacobse JN, Schaapveld M, et al. Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer. Br J Cancer. 2018;119(4):408–418.
   PubMed Web of Science ®Google Scholar
• Donnellan E, Griffin BP, Johnston DR, et al. Rate of progression of aortic stenosis and its impact on outcomes in patients with radiation-associated cardiac disease: a matched cohort study. J Am Coll Cardiol Img. 2018;11(8):1072–1080.
   Google Scholar
• Agrawal N, Kattel S, Waheed S, et al. Clinical outcomes after transcatheter aortic valve replacement in cancer survivors treated with ionizing radiation. Cardio-Oncology. 2019;5(1):8.
   PubMedGoogle Scholar
• Fathala A, Saeedan M, Zulfiqar A, et al. Non-cardiovascular computed tomography incidental findings in patients who underwent transaortic valve implantation procedure. Cardiol Res. 2017;8(1):13–19.
   Google Scholar
• Tops LF, Wood DA, Delgado V, et al. Noninvasive evaluation of the aortic root with multislice computed tomography implications for transcatheter aortic valve replacement. JACC Cardiovasc Imaging. 2008;1(3):321–330.
   PubMed Web of Science ®Google Scholar
• Schultz CJ, Moelker AD, Tzikas A, et al. necessary for precise sizing for transcatheter aortic implantation. EuroIntervention. 2010;6(SupplG):G6–G13.
   PubMedGoogle Scholar
• Lindsay AC, Sriharan M, Lazoura O, et al., Clinical and economic consequences of non-cardiac incidental findings detected on cardiovascular computed tomography performed prior to transcatheter aortic valve implantation (TAVI). Int J Cardiovasc Imaging. 31(7): 1435–1446. 2015.
   PubMed Web of Science ®Google Scholar
• Bach DS, Siao D, Girard SE, et al. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ Cardiovasc Qual Outcomes. 2009;2:533–539.
   PubMed Web of Science ®Google Scholar
• Staab W, Bergau L, Lotz J, et al. Prevalence of noncardiac findings in computed tomography angiography before transcatheter aortic valve replacement. J Cardiovasc Comput Tomogr. 2014;8(3):222–229.
   PubMed Web of Science ®Google Scholar
• Gufler H, Schulze CG, Wagner S. Incidental findings in computed tomographic angiography for planning percutaneous aortic valve replacement: advanced age, increased cancer prevalence? Acta Radiol. 2014;55(4):420–426.
   PubMed Web of Science ®Google Scholar
• Stachon P, Kaier K, Milde S, et al. Two-year survival of patients screened for transcatheter aortic valve replacement with potentially malignant incidental findings in initial body computed tomography. Eur Heart J Cardiovasc Imaging. 2015;16(7):731–737.
   PubMed Web of Science ®Google Scholar
• Lee HY, Kim SM, Lee KS, et al. Quantification of aortic valve calcifications detected during lung cancer-screening CT helps stratify subjects necessitating echocardiography for aortic stenosis diagnosis. Medicine (Baltimore). 2016;95(19):e3710.
   PubMed Web of Science ®Google Scholar
• Carabello BA. Aortic stenosis: a fatal disease with but a single cure. JACC Cardiovasc Interv. 2008;1(2):127–128.
   PubMed Web of Science ®Google Scholar
• Ashikhmina EA, Schaff HV, Dearani JA, et al. Aortic valve replacement in the elderly: determinants of late outcome. Circulation. 2011;124(9):1070–1078.
   PubMed Web of Science ®Google Scholar
• Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26(24):2714–2720.
   PubMed Web of Science ®Google Scholar
• Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2477–2484.
   PubMed Web of Science ®Google Scholar
• Walther T, Hamm CW, Schuler G, et al. Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry. J Am Coll Cardiol. 2015;65(20):2173–2180.
   PubMed Web of Science ®Google Scholar
• Arangalage D, Cimadevilla C, Alkhoder S, et al. Agreement between the new EuroSCORE II, the logistic EuroSCORE and the society of thoracic surgeons score: implications for transcatheter aortic valve implantation. Arch Cardiovasc Dis. 2014;107(6–7):353–360.
   PubMed Web of Science ®Google Scholar
• Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol. 2007;50(20):2018–2019.
   PubMed Web of Science ®Google Scholar
• Yusuf SW, Sarfaraz A, Durand JB, et al. Management and outcomes of severe aortic stenosis in cancer patients. Am Heart J. 2011;161(6):1125–1132.
   PubMed Web of Science ®Google Scholar
• Samuels LE, Kaufman MS, Morris RJ, et al. Open heart surgery in patients with chronic lymphocytic leukemia. Leuk Res. 1999;23(1):71–75.
   PubMed Web of Science ®Google Scholar
• Bendary A, Ramzy A, Bendary M, et al., Transcatheter aortic valve replacement in patients with severe aortic stenosis and active cancer: a systematic review and meta-analysis. Open Heart. 2020; 7(1): e001131.
   PubMed Web of Science ®Google Scholar
• Tabata N, Al-Kassou B, Sugiura A, et al. Prognostic impact of cancer history in patients undergoing transcatheter aortic valve implantation. Clin Res Cardiol. 2020;109(10):1243–1250.
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Volkmar Falk V, Bax J, et al. ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;2017(38):2739–2791.
   Google Scholar
• Nishimura R, Otto C, Bonow R, et al. AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J Am Coll Cardiol. 2017;2017(70):252–289.
   Google Scholar
• Sablotzki A, Welters I, Lehmann N, et al. Plasma levels of immunoinhibitory cytokine interleukin-10 and transforming growth factor-β in patients undergoing coronary artery bypass grafting. Eur J Cardio Thorac Surg. 1997;11(4):763–768.
   PubMed Web of Science ®Google Scholar
• Akbas H, Erdal A, Demiralp E, et al. Effects of coronary artery bypass grafting on cellular immunity with or without cardiopulmonary bypass. Cardiovasc Surg. 2002;10(6):586–589.
   PubMedGoogle Scholar
• Suzuki S, Usui A, Yoshida K, et al. Effect of cardiopulmonary bypass on cancer prognosis. Asian Cardiovasc Thorac Ann. 2010;18(6):536–540.
   PubMedGoogle Scholar
• Plumereau F, Pinaud F, Roch A, et al. Do patients with haematological malignancy who need cardiopulmonary bypass have a short-term higher mortality or a higher chance of disease progression? Interact Cardiovasc Thorac Surg. 2014;19(3):474–478.
   PubMed Web of Science ®Google Scholar
• Pinto CA, Marcella S, August DA, et al. Cardiopulmonary bypass has a modest association with cancer progression: a retrospective cohort study. BMC Cancer. 2013;13(1):519.
   PubMedGoogle Scholar
• Carrascal Y, Gualis J, Arevalo A, et al. Cardiac surgery with extracorporeal circulation in cancer patients: influence on surgical morbidity and mortality and on survival. Rev Esp Cardiol. 2008;61(4):369–375.
   PubMed Web of Science ®Google Scholar
• Lorusso R, Vizzardi E, Johnson DM, et al., Cardiac surgery in adult patients with remitted or active malignancies: a review of preoperative screening, surgical management and short- and long-term postoperative results. Eur J Cardiothorac Surg. 2018; 54(1): 10–18.
   PubMed Web of Science ®Google Scholar
• Chan J, Rosenfeldt F, Chaudhuri K, et al. Cardiac surgery in patients with a history of malignancy: increased complication rate but similar mortality. Heart Lung Circ. 2012;21(5):255–259.
   PubMed Web of Science ®Google Scholar
• Fu Q, Li Q, Liang D, et al. Early and long-term results of combined cardiac surgery and neoplastic resection in patients with concomitant severe heart disease and neoplasms. Chin Med J. 2011;124(13):1939–1942.
   PubMed Web of Science ®Google Scholar
• Davydov MI, Akchurin RS, Gerasimov SS, et al. Simultaneous operations in thoraco-abdominal clinical oncology. Eur J Cardiothorac Surg. 2001;20(5):1020–1024.
   PubMed Web of Science ®Google Scholar
• Komokata T, Fukueda M, Kaieda M, et al. Simultaneous operation for cardiac disease and gastrointestinal malignancy. World J Gastrointest Surg. 2014;6(8):146–150.
   PubMedGoogle Scholar
• Potapov EV, Zurbru¨gg HR, Herzke C, et al. Impact of cardiac surgery using cardiopulmonary bypass on course of chronic lymphatic leukemia: a case-control study. Ann Thorac Surg. 2002;74(2):384–389.
   PubMed Web of Science ®Google Scholar
• Mistiaen WP, Van Cauwelaert P, Muylaert P, et al. Effect of prior malignancy on survival after cardiac surgery. Ann Thorac Surg. 2004;77(5):1593–1597.
   PubMed Web of Science ®Google Scholar
• Szeto WY, Svensson LG, Rajeswaran J, et al. Appropriate patient selection or health care rationing? Lessons from surgical aortic valve replacement in the placement of aortic transcatheter valves I trial. J Thorac Cardiovasc Surg. 2015;150(3):557–68.e11.
   PubMed Web of Science ®Google Scholar
• Swain SM, Kim SB, Cortés J, et al. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. Lancet Oncol. 2013;14(6):461–471.
   PubMed Web of Science ®Google Scholar
• Mrak M, Ambrozic J, Music S, et al. Transcatheter aortic valve implantation in a cancer patient denied for surgical aortic valve replacement – a case report. Wien Klin Wochenschr. 2016;128(13–14):516–520.
   PubMed Web of Science ®Google Scholar
• Komatsu H, Izumi N, Tsukioka T, et al. Pulmonary resection for lung cancer following transcatheter aortic valve implantation for severe aortic valve stenosis: a case report. Ann Thorac Cardiovasc Surg. 2018. 10.5761/atcs.cr.18-00028
   Web of Science ®Google Scholar
• Sakai T, Yahagi K, Miura S, et al. Transcatheter aortic valve implantation for patients with lung cancer and aortic valve stenosis. J Thorac Dis. 2018;10(5):E387–e90.
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Kozuma K, Hioki H, et al. Comparison of results of transcatheter aortic valve implantation in patients with versus without active cancer. Am J Cardiol. 2016;118(4):572–577.
   PubMed Web of Science ®Google Scholar
• Landes U, Iakobishvili Z, Vronsky D, et al. Transcatheter aortic valve replacement in oncology patients with severe aortic stenosis. JACC Cardiovasc Interv. 2019;12(1):78–86.
   PubMed Web of Science ®Google Scholar
• Kogoj P, Devjak R, Bunc M. Balloon aortic valvuloplasty (BAV) as a bridge to aortic valve replacement in cancer patients who require urgent non-cardiac surgery. Radiol Oncol. 2014;48(1):62–66.
   PubMed Web of Science ®Google Scholar
• Cioffi G, Tomasi C, Rossi A, et al. Does treatment assignment influence the prognosis of patients with symptomatic severe aortic stenosis? Cardiovasc Ultrasound. 2015;13(1). 10.1186/1476-7120-13-2
   PubMedGoogle Scholar